Clinical Data Acquires Epidauros Biotechnologie

Clinical Data has acquired the privately held German drug company Epidauros Biotechnologie.

Clinical Data said the transaction brings a significant intellectual property portfolio that includes biomarkers in genes relating to prominent drug transporters such as MDR1, OCT1, MRP1 and important cytochrome P450 drug metabolizing genes, such as CYP2B6 and CYP2D6.

MDR1 encodes P-glycoprotein, a key protein involved in drug transport that modulates drug disposition. The genes CYP2B6, OCT1 and MRP1 are implicated in the absorption, distribution and metabolism of many drugs that span a variety of therapeutic classes and indications, and are likely to be important in both response and safety profiles for these drugs.

Drew Fromkin, Clinical Data’s president and CEO, said that with the acquisition, the company will now have a presence in Germany, the UK and France.